ofev - nintedanib capsule
(Nintedanib)Boehringer Ingelheim Pharmaceuticals, Inc.
Usage: OFEV treats adults with idiopathic pulmonary fibrosis (IPF), chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype, and slows pulmonary function decline in systemic sclerosis-associated interstitial lung disease (SSc-ILD).